The World Health Organization and the Pharmaceutical Industry: Common Areas of Interest and Differing Views

ISSN： 1176-2551

Source： Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol.21, Iss.1-2, 2002-01, pp. : 51-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmaceutical industry failing the developing world

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 369, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Health Economics in the Canadian Pharmaceutical Industry

By Assiff L.

PharmacoEconomics, Vol. 16, Iss. 6, 1999-12 ,pp. : 669-678

Adis International

Access to resources Recommend Favorite

World Health Organization's International Radon Project

By Zielinski Jan Carr Zhanat Krewski Daniel Repacholi Michael

Journal of Toxicology and Environmental Health, Vol. 69, Iss. 7-8, 2006-05 ,pp. : 759-769

Taylor & Francis Ltd

Access to resources Recommend Favorite

World Health Organization Classification of Myelodysplastic Syndromes

Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. : 3149-3162

Bentham Science Publishers

Access to resources Recommend Favorite

Immunisation Safety: A Priority of the World Health Organization's Department of Vaccines and Biologicals

By Duclos P. Hofmann C-A.

Drug Safety, Vol. 24, Iss. 15, 2001-01 ,pp. : 1105-1112

Adis International

Access to resources Recommend Favorite